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Colorectal cancer is a leading contributor to cancer-related 
deaths in the United States and is a major complication of 
inflammatory bowel disease (IBD; Clevers, 2004). Colorec-
tal cancer and IBD are commonly associated with the ex-
aggerated production of inflammatory cytokines, which are 
regulated by the activation of various cell signaling pathways 
(Karin and Greten, 2005; Yu et al., 2009; Saleh and Trinch-
ieri, 2011; West et al., 2015). It has been well established that 
STAT3 and IL-10 play critical roles in the regulation of intes-
tinal inflammation in both IBD patients and animals with ex-
perimental colitis. Genome-wide association studies indicated 
that STAT3 gene polymorphism is associated with increased 
susceptibility to IBD (Barrett et al., 2008; Jostins et al., 2012). 
Myeloid-derived STAT3 exerts a potent anti-inflammatory 
effect on chemically induced experimental colitis (Takeda et 
al., 1999). Meanwhile, STAT3 is important for survival and 
proliferation of intestinal epithelial cells (Bollrath et al., 2009; 
Grivennikov et al., 2009).
Recent studies of immune system metabolism, namely 
immunometabolism, have identified a tight link between 
metabolic reprogramming and hyperinflammation. It has 
been well documented that activation of immune cells is ac-
companied by metabolic changes toward increased glucose 
uptake, glycolysis, and pentose phosphate pathway activity 
(O’Neill and Hardie, 2013; Pearce et al., 2013). In addition 
to glycolysis and pentose phosphate pathway, a small portion 
of glucose metabolizes through the hexosamine biosynthesis 
pathway (HBP), which leads to the generation of its end prod-
uct, UDP–N-acetylglucosamine (UDP-GlcNAc; Ruan et al., 
2013). O-GlcNAc transferase (OGT) mediates the transfer of 
UDP-GlcNAc to serine or threonine residue of target proteins, 
which is called protein O-GlcNAcylation. Previous studies 
have discovered essential roles of protein O-GlcNAcylation 
in many fundamental biological activities, including signaling, 
transcription, and translation (Hart et al., 2011). A very re-
cent study revealed a critical role of OGT in both T progen-
itor cell development in the thymus and mature T cell clonal 
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expansion in the periphery (Swamy et al., 2016). Through 
metabolic profiling analysis, another study indicated that 
HBP is required for macrophage alternative activation 
(Jha et al., 2015), although a genetic animal model is fur-
ther required to test this concept. The overall effect of OGT- 
mediated O-GlcNAcylation in innate immune function and 
its disease relevance remain elusive (Pearce and Everts, 2015).
Cullin-RING (really interesting new gene) ligases 
(CRLs) represent the largest E3 ubiquitin ligase family in 
eukaryotes (Genschik et al., 2013). Within the CRL fam-
ily, CUL3-formed CRL3 has been reported to target more 
than 100 substrates for protein ubiquitination and degrada-
tion (Emanuele et al., 2011). Previous studies have established 
CUL3 as an essential regulator of a variety of important bi-
ological processes, including cell cycle, development, and cell 
stress response (Genschik et al., 2013). Recent studies have re-
vealed a critical role of CUL3 in the adaptive immune system, 
including promoting germinal center B cell and NKT cell 
differentiation (Mathew et al., 2012) and inhibiting T follicu-
lar helper cell differentiation (Mathew et al., 2014). However, 
the role of CUL3 in the innate immune system and inflam-
mation is not clear. In this study, we observed increased OGT 
expression and STAT3 O-GlcNAcylation in Cul3-deficient 
macrophages as a result of elevated Nrf2-mediated Ogt gene 
transcription. We also found that O-GlcNAcylation of STAT3 
on T717 exerts an inhibitory effect on STAT3 phosphory-
lation and IL-10 production in macrophages and promotes 
disease severity in chemically induced colitis and a colitis-as-
sociated cancer (CAC) model. Our findings demonstrate a 
mechanistic link between O-GlcNAc signaling and STAT3 
function during intestinal inflammation and tumorigenesis.
rESuLtS
defective StAt3 phosphorylation and IL-10 production  
in cul3-deficient macrophages
A previous study reported that whole-body deletion of CUL3 
caused embryonic lethality (Singer et al., 1999). To examine 
the role of CUL3 in the innate immune system, we generated 
mice with a myeloid-conditional Cul3 deletion (Cul3Δmye) 
by crossing Cul3fl/fl mice (McEvoy et al., 2007) with lyso-
some M-Cre mice (Fig. S1 A). Cul3fl/fl mice were used as 
WT controls. Deletion of CUL3 protein in Cul3Δmye BM-de-
rived macrophages (BMMs) was confirmed (Fig. S1 B). As 
a well-defined CRL3 target (Genschik et al., 2013), nuclear 
factor E2–related factor-2 (Nrf2) protein (Fig. S1 C) and its 
target gene Nqo1 transcripts (Fig. S1 D) were both dramati-
cally increased in Cul3Δmye BMMs. These findings confirmed 
a successful CUL3 deletion in Cul3Δmye macrophages.
We tested the activation of various immune signaling 
pathways in Cul3Δmye macrophages. Cul3Δmye BMMs showed 
dramatically decreased STAT3 phosphorylation at Y705 in 
response to either LPS (Fig. 1 A) or IL-6 (Fig. 1 B). In con-
trast, Cul3Δmye BMMs exhibited slightly decreased NF-κB 
(Fig. 1 C), intact MAPK (Fig. 1 D) signaling upon LPS stim-
ulation, intact STAT1 phosphorylation upon IFN-γ stimu-
lation (Fig.  1  E), and intact STAT6 phosphorylation upon 
IL-4 stimulation (Fig. 1 F). LPS-induced STAT3 phosphory-
lation and up-regulation of suppressor of cytokine signaling 3 
(SOCS3), a well-defined STAT3 transcriptional target, were 
also blunted in Cul3Δmye peritoneal macrophages (Fig. 1 G). 
These findings indicate a specific role of CUL3 in STAT3 
phosphorylation in macrophages independent of stimuli.
It has been shown that STAT3 is a key transcriptional 
factor mediating IL-10 production (Takeda et al., 1999). 
Cul3Δmye macrophages generated significantly lower levels of 
Il10 but higher levels of Il12a, Cxcl1, and Cxcl2 transcripts 
(Fig. 2 A), and a lower amount of IL-10 and higher amount 
of IL-12p70 protein upon LPS stimulation (Fig. 2 B). Mac-
rophages activated by TLR2 (Pam3Cys) or TLR9 (CpG) 
agonists showed a similar phenotype (Fig. 2, C and D), sug-
gesting a broad hyperinflammatory response in Cul3Δmye 
macrophages. Chromatin immunoprecipitation (ChIP) assays 
showed defective STAT3 binding at the promoter region of 
Il10 gene in LPS-stimulated Cul3Δmye macrophages, suggest-
ing that CUL3 mediates TLR-induced STAT3 activation to 
cause chromosomal activation of Il10 promoter (Fig. 2 E).
STAT3 is a well-established signal transducer of the 
cytokine–cytokine receptor signaling pathway (O’Shea and 
Plenge, 2012). To examine whether defective STAT3 phos-
phorylation is caused by an altered extracellular cytokine 
environment for Cul3Δmye macrophages, we used a Transwell 
co-culture system in which Cul3f/fl and Cul3Δmye macro-
phages placed in distinct chambers shared an identical cyto-
kine environment. Despite the genotypes of co-cultured cells 
in the upper chamber, Cul3Δmye BMMs in the lower chamber 
showed decreased STAT3 phosphorylation (Fig. 2 F), lower 
levels of Il10, and higher levels of Il12a, Cxcl1, and Cxcl2 
transcripts (Fig.  2 G) after LPS stimulation compared with 
similarly treated WT BMMs (Fig. 2 F). These findings sup-
port a cell-intrinsic mechanism of CUL3 in mediating the 
STAT3–IL-10 signaling axis.
cuL3 negatively regulates oGt expression  
and protein o-GlcnAcylation
We next performed microarray analysis to explore the mech-
anism by which CUL3 mediates the STAT3–IL-10 signal-
ing axis. After LPS stimulation, Cul3Δmye BMMs generated 
lower transcript levels of Il10 and several other STAT3 tar-
get genes, including Ahr (aryl hydrocarbon receptor), Klf4 
(Kruppel-like factor 4), and Ccnd1 (cyclin D1; Fig.  3  A 
and Table S3; Yu et al., 2009). Several Nrf2 target genes, in-
cluding Gss (glutathione synthetase), Gstm2 (GST Mu 2), 
Gstt2 (GST theta 2), Gstm3, and Gstm1 were expressed in 
Cul3Δmye BMMs at higher levels (Fig. 3 B), presumably be-
cause of elevated Nrf2 protein levels (Fig. S1 C). Interestingly, 
we observed higher expression of Ogt, which encodes a key 
enzyme for protein O-GlcNAcylation, in LPS-stimulated 
Cul3Δmye BMMs compared with similarly treated WT BMMs 
(Fig. 3 A and Table S3). RT-PCR analysis revealed that com-
pared with WT BMMs, Cul3Δmye BMMs show a two- and 
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threefold increase in Ogt transcript levels in naive status and 
upon LPS stimulation, respectively (Fig.  3 C). In line with 
increased Ogt transcript levels, Cul3Δmye BMMs contained 
markedly increased OGT protein levels (Fig.  3  D), as well 
as increased total O-GlcNAcylation (Fig. 3 D). It should be 
noted that despite reduced Ogt transcript levels, LPS stimu-
lation up to 8 h failed to decrease OGT protein levels, indi-
cating a prolonged half-life of OGT protein, as was recently 
reported (Yang et al., 2015a).
To gain further insight into the effect of CUL3 on 
HBP activity, we performed targeted steady-state metabolo-
mics profiling by mass spectrometry (MS; Yuan et al., 2012) 
in macrophages with or without LPS stimulation (Fig. 3 E). 
Compared with WT macrophages, we observed two- and 
fourfold increases in glucosamine-6-phosphate (GlcN-6P), 
the product of the committed step governing entry into HBP, 
in Cul3Δmye BMMs in naive status and upon LPS stimulation, 
respectively (Fig. 3 F and Table S4). These data suggest in-
creased HBP activity in the absence of CUL3.
cuL3 inhibits StAt3 o-GlcnAcylation
Previous studies suggested extensive cross-talk between 
O-GlcNAcylation and phosphorylation (Hart et al., 2011). 
The observation of defective STAT3 phosphorylation but 
increased total O-GlcNAcylation in Cul3Δmye macrophages 
prompted us to test the hypothesis that increased STAT3 
O-GlcNAcylation inhibits its phosphorylation. We first 
measured STAT3 O-GlcNAcylation in Cul3fl/fl and Cul3Δmye 
macrophages by STAT3 immunoprecipitation, followed by 
immunoblotting with anti–O-GlcNAc antibody (because 
of the lack of specific antibody against O-GlcNAcylated 
STAT3). Cul3Δmye macrophages showed a twofold increase 
in O-GlcNAcylated STAT3 normalized to total STAT3 
compared with WT cells (Fig. 4, A and B). The O-GlcNAc 
signal on STAT3 was abolished when anti–O-GlcNAc an-
tibody was preincubated with 500 mM GlcNAc, indicating 
the specificity of the O-GlcNAc signal (Fig. 4 A). In con-
trast, LPS-induced STAT3 phosphorylation was dramat-
ically attenuated in LPS-stimulated Cul3Δmye macrophages, 
suggesting a negative correlation between STAT3 O- 
GlcNAcylation and phosphorylation. We tested the relation-
ship between STAT3 O-GlcNAcylation and phosphoryla-
tion using a pharmacological HBP activator. PUG NAc is 
a widely used inhibitor of O-GlcNAcase (OGA) that can 
potently enhance protein O-GlcNAcylation (Hart et al., 
2011), and we confirmed its effect on promoting protein O- 
Figure 1. cuL3 is required for StAt3 phosphorylation in macrophages. (A and B) BMMs generated from Cul3fl/fl and Cul3Δmye mice were stimulated 
with 200 ng/ml LPS (A) or IL-6 (B) for the indicated periods. IKK, IκB kinase. Phosphorylation of STAT3 (Y705) was assayed with immunoblotting. (C and D) 
Immunoblotting of NF-κB (C) and MAPK (D) signaling molecules was performed in Cul3fl/fl and Cul3Δmye BMMs left untreated or treated with LPS for the 
indicated periods. ERK, extracellular signal–regulated kinase. (E and F) Immunoblotting of STAT1 phosphorylation (Y701) in response to 20 ng/ml IFN-γ (E) 
and STAT6 phosphorylation (Y641) in response to 20 ng/ml IL-4 (F) was performed in Cul3fl/fl and Cul3Δmye BMMs. (G) Immunoblotting of phosphorylated 
STAT3 (Y705) and its target protein suppressor of cytokine signaling 3 (SOCS3) was performed in peritoneal macrophages isolated from naive Cul3fl/fl and 
Cul3Δmye mice left untreated or treated with LPS for the indicated periods. The results are representative of three independent experiments.
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GlcNAcylation in macrophages (Fig.  4  C). We found that 
PUG NAc pretreatment dramatically attenuated LPS-in-
duced STAT3 phosphorylation (Fig.  4 C) and IL-10 pro-
duction (Fig.  4, D and E) in WT cells and abolished the 
differences between WT and Cul3Δmye macrophages. We 
next asked whether the inhibitory effect of STAT3 O- 
GlcNAcylation on its phosphorylation occurred in a physio-
logical condition by lowering culture medium glucose level. 
Switching the glucose level from 25 to 5  mM in culture 
medium caused a decrease in total O-GlcNAcylation and 
Figure 2. cuL3 mediates StAt3 phosphorylation and IL-10 production via a cell-intrinsic mechanism. (A–D) Cul3fl/fl and Cul3Δmye BMMs were left 
untreated or stimulated with 200 ng/ml LPS (A and B) for the indicated periods, 500 ng/ml PamCy3 (TLR2 agonist), or 5 µg/ml CpG oligonucleotide (TLR9 
agonist; C and D) for 6 h. Cytokine transcripts including Il10, Il12a, Cxcl1, and Cxcl2 in the cells (A and C) and IL-10 and IL-12p70 proteins in the supernatants 
(B and D) were measured with RT-PCR and ELI SA, respectively. NT, not treated. (E) ChIP assay of the binding of STAT3 at the promoter region of Il10 gene 
in Cul3fl/fl and Cul3Δmye BMMs left untreated or stimulated with LPS for 3 or 6 h. (F and G) Cul3fl/fl and Cul3Δmye BMMs were placed in either the upper or 
lower chamber of the Transwell co-culture system, followed by stimulation with LPS for the indicated periods. STAT3 phosphorylation (Y705; F) and cytokine 
transcripts including Il10, Il12a, Cxcl1, and Cxcl2 (G) in the cells placed in the lower chambers were assayed by immunoblotting and RT-PCR, respectively. 
The results shown are representative of three independent experiments and are expressed as mean ± SD. *, P < 0.05 versus controls.
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an increase in STAT3 phosphorylation upon LPS stimula-
tion (Fig. 4 F). These results indicate that glucose metabolism 
affects STAT3 phosphorylation through O-GlcNAc signaling.
Finally, we used siRNA-based Ogt gene knockdown 
to determine whether defective STAT3 phosphorylation and 
IL-10 production were dependent on elevated OGT expres-
sion in Cul3Δmye macrophages. Transfection with siOgt mark-
edly rescued defective STAT3 phosphorylation (Fig.  4 G) 
and IL-10 production (Fig. 4 H) in Cul3Δmye macrophages 
compared with scrambled siRNA transfection. Collectively, 
these results indicate that CUL3 mediates STAT3 phosphor-
ylation and IL-10 production through an O-GlcNAcylation– 
dependent mechanism.
StAt3 is o-GlcnAcylated on t717
We sought to identify the O-GlcNAcylation site or sites 
on STAT3 through MS analysis. Mouse livers were initially 
used as the model system because of their abundant STAT3 
Figure 3. cuL3 negatively regulates oGt expression and protein o-GlcnAcylation. (A and B) Gene profiling assay was performed with RNA samples 
extracted from Cul3fl/fl and Cul3Δmye BMMs stimulated with LPS for 4 h. A resultant heat map indicating Il10 and Ogt (A) and fold changes in Nrf2 target 
genes (B) are shown. (C and D) Cul3fl/fl and Cul3Δmye BMMs were left untreated or stimulated with 200 ng/ml LPS for the indicated periods. (C) Ogt transcript 
was measured with RT-PCR. (D) Immunoblotting (left) and densitometric analysis to quantify ratio of OGT to actin (right) in treated BMMs. (E and F) Cul3fl/fl 
and Cul3Δmye BMMs were left untreated or stimulated with 200 ng/ml LPS for 4 h. LC-MS/MS metabolomics analysis was performed to profile steady-state 
metabolites. A summary of HBP (E) and fold changes in HBP intermediate metabolites (F) are shown. In A, B, and F, the microarray and metabolomics 
experiment were performed once each, and the results in F are expressed as mean ± SD of duplicates. In C and D, the results are representative of three 
independent experiments and are expressed as mean ± SD. *, P < 0.05 versus controls.
Cullin 3 is required for STAT3 phosphorylation | Li et al.1098
Figure 4. cuL3 inhibits StAt3 o-GlcnAcylation on t717. (A and B) Total STAT3 was immunoprecipitated (IP) from Cul3fl/fl and Cul3Δmye BMMs left 
untreated or stimulated with 200 ng/ml LPS for 4 h. Immunoblotting (A) and densitometric analysis to quantify ratio of either O-GlcNAcylated or phos-
phorylated STAT3 to total STAT3 (B) are shown. (C–E) Cul3fl/fl and Cul3Δmye BMMs were left untreated or stimulated with LPS for the indicated periods with or 
without pretreatment with 100 µM HBP activator PUG NAc. STAT3 phosphorylation (Y705) and total protein O-GlcNAcylation (C) and IL-10 transcript (D) and 
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protein supply. A recent study suggested that the ER stress 
response promotes HBP activity and protein O-GlcNAcyla-
tion (Wang et al., 2014). We challenged C57BL/6 mice with 
vehicle or tunicamycin (Tm), a pharmacological inhibitor of 
protein glycosylation that is commonly used to induce ER 
stress (Ozcan et al., 2004). As expected, Tm challenge for 6 h 
caused the up-regulation of spliced X-box binding protein 
1 (Xbp1s) and C/EBP homologous protein (CHOP), two 
ER stress target proteins (Fig.  4  I; Ozcan et al., 2004). In-
terestingly, Tm challenge dramatically enhanced STAT3 O- 
GlcNAcylation. In line with the negative correlation between 
STAT3 O-GlcNAcylation and phosphorylation observed in 
Cul3Δmye macrophages (Fig.  4 A), Tm challenge resulted in 
decreased STAT3 phosphorylation, a finding similar to that 
previously reported (Kimura et al., 2012). Therefore, mouse 
liver after ER stress induction serves as an ideal subject for 
proteomics analysis of STAT3 O-GlcNAcylation sites.
Immunoprecipitated STAT3 in total liver lysates pre-
pared from vehicle- or Tm-treated mice was analyzed by liq-
uid chromatography coupled to tandem MS (LC-MS/MS). 
A single peptide FIC VTP TTC SNT IDL PMS PR (amino acid 
710–729) was identified as carrying a HexNAc (+203.1 D) 
modification in liver sample from Tm-treated mouse, but 
not in that from vehicle-treated mouse (Fig.  4  J). Because 
of sufficient fragmentation by collision-induced dissociation 
(CID), the O-GlcNAc modification was localized to T717, 
whereas other potential O-GlcNAcylation sites (T714, T716, 
T721, and S727) in this peptide could not be confirmed. 
We also identified the phosphorylation of Y705 and S727, 
which was decreased in the Tm-treated mice (Fig. 4 J). These 
findings demonstrate a negative correlation between STAT3 
O-GlcNAcylation and phosphorylation during ER stress. 
We further confirmed the aforementioned findings by an-
alyzing Stat3 O-GlcNAcylation in mouse BMMs. In both 
nontreated and LPS-treated BMMs, the same peptide of Stat3 
(amino acid 710–729), as observed in mouse liver Stat3, car-
ried a HexNAc modification (Fig. S2). Therefore, the results 
from MS assay confirmed the biochemical analysis results of 
STAT3 O-GlcNAcylation (Fig. 4 A).
A series of mutant constructs of STAT3 were generated 
with those individual residues as potential O-GlcNAcylation 
sites mutated to alanine. To examine STAT3 O-GlcNAcylation 
sites, we transfected STAT3 WT or mutant constructs into 
Cul3Δmye macrophages, which represent a highly permis-
sive environment for STAT3 O-GlcNAcylation (Fig.  4 A). 
STAT3 with T717A mutation showed a loss of O-GlcNAc 
signal, indicating that STAT3 is O-GlcNAcylated at T717 
(Fig. 4 K). Macrophages transfected with STAT3 T717A mu-
tant exhibited significantly increased STAT3 phosphorylation 
(Fig. 4 K) and IL-10 production at the transcript (Fig. 4 L) 
and protein (Fig. 4 M) levels upon LPS stimulation, compared 
with those transfected with WT STAT3. In agreement, ChIP 
assay revealed an increased binding of STAT3 T717A mutant 
to the Il10 promoter region, indicating an increased tran-
scription activity in STAT3 upon the loss of O-GlcNAcyla-
tion (Fig. 4 N). Collectively, these data strongly indicate that 
STAT3 O-GlcNAcylation on T717 is an intrinsic inhibitory 
mechanism against its phosphorylation and transcriptional 
activity. Interestingly, STAT3 T717 and phosphorylation site 
Y705 are well conserved among metazoan species (Fig. 4 O), 
highlighting the cross-talk between O-GlcNAcylation on 
T717 and phosphorylation on Y705 as an evolutionarily con-
served mechanism regulating STAT3 biological activity.
Previous studies suggest that OGT forms a functional 
protein complex with the serine/threonine phosphatase 1 
(PP1; Wells et al., 2004). We therefore sought to determine 
whether PP1 is involved in the inhibitory effect of STAT3 
O-GlcNAcylation on its phosphorylation. Pretreatment of 
cells with calyculin A, a widely used PP1 and PP2A inhib-
itor, increased LPS-induced Stat3 phosphorylation in both 
WT and Cul3Δmye cells (Fig. S3), which is consistent with pre-
vious study showing an antagonizing effect of protein phos-
phatase in STAT3 phosphorylation (Zgheib et al., 2012). 
However, decreased STAT3 phosphorylation was still observed 
in Cul3Δmye cells compared with WT cells in the presence of 
calyculin A, suggesting that PP1 or PP2A is not involved in 
the inhibitory effect of O-GlcNAcylation on phosphorylation 
of STAT3. Therefore, the mechanism whereby STAT3 O- 
GlcNAcylation inhibits its phosphorylation remains unidentified.
Elevated nrf2 protein mediates increased ogt transcription 
in cul3Δmye macrophages
It is reasonable to hypothesize that certain CUL3-regulated 
transcriptional factors are responsible for elevated OGT lev-
protein (E) were assayed by immunoblotting, RT-PCR, and ELI SA, respectively. (F) STAT3 phosphorylation (Y705) was measured in WT BMMs left untreated or 
stimulated with LPS for 3 or 6 h in the presence of 5 or 25 mM glucose. (G and H) Cul3fl/fl and Cul3Δmye BMMs transfected with siScr or siOgt were left un-
treated or stimulated with LPS for 6 h. STAT3 phosphorylation (G) and IL-10 production (H) were assayed. (I and J) Total STAT3 was immunoprecipitated from 
liver tissue lysates of vehicle- or Tm-treated C57BL/6 mice. (I) Immunoblotting (left) and densitometric analysis (right) to quantify STAT3 O-GlcNAcylation 
and phosphorylation (Y705). (J) LC-MS/MS analysis was performed to identify T717 as a STAT3 O-GlcNAcylation site after Tm challenge. MS/MS spectrum 
of the 2+ ion at m/z 1,265.08667 corresponding to STAT3 peptide FIcVTPTgTcSNT IDLPmSPR. T177 is O-GlcNAcylated (gT). (K–N) A series of point mutations 
of STAT3 were generated with site-directed mutagenesis, as indicated. (K) Empty vector, FLAG-tagged WT, or mutant constructs of STAT3 were transfected 
into Cul3Δmye BMMs for 48 h, followed by LPS stimulation for 6 h. STAT3 O-GlcNAcylation was assayed as described in A. (L and M) IL-10 transcript (L) and 
protein (M) were measured by RT-PCR and ELI SA, respectively. (N) ChIP assay was performed to measure the binding of WT or mutant constructs of STAT3 at 
the promoter region of Il10 gene. NT, not treated. (O) Cross-species sequence alignment of STAT3 revealed conserved O-GlcNAcylation site T717 and phos-
phorylation site Y705. In G, the LC-MS/MS experiment was performed once. In other experiments, the results are representative of three to five independent 
experiments and are expressed as mean ± SD. *, P < 0.05 versus controls.
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els in Cul3Δmye macrophages because the inhibitory effect of 
CUL3 on OGT occurs at the transcriptional level. Nrf2 has 
been firmly established as a target protein of CUL3-medi-
ated protein ubiquitination and degradation (Emanuele et 
al., 2011), which has been confirmed in our hands (Fig. S1). 
We therefore tested whether elevated Nrf2 is an underlying 
mechanism for increased OGT transcription and decreased 
STAT3–IL-10 axis in Cul3Δmye macrophages by generating 
Cul3ΔmyeNrf2−/− double KO (DKO) mice. Although Nrf2−/− 
macrophages showed normal OGT expression compared 
with WT cells, deletion of Nrf2 abolished increased OGT 
expression at the transcript (Fig. 5 A) and protein (Fig. 5 B) 
levels, as well as elevated total O-GlcNAc signal, in Cul3Δmye 
macrophages. As a result, elevated STAT3 O-GlcNAcylation 
in Cul3Δmye macrophages was also abolished in DKO cells 
(Fig. 5 C). This result suggests that Nrf2 is not absolutely re-
quired for OGT expression, but elevated Nrf2 protein can 
increase OGT expression. Similar results were observed in au-
tophagy-deficient macrophages showing increased MAR CO 
(macrophage receptor with collagenous structure) expression 
caused by enhanced Nrf2 activation (Bonilla et al., 2013).
We took advantage of DKO macrophages to test 
the potential link between elevated Nrf2 and defective 
STAT3-IL-10 axis in Cul3Δmye macrophages. After LPS stim-
ulation, defective STAT3 phosphorylation in Cul3Δmye mac-
rophages was rescued in DKO macrophages (Fig.  5, B and 
C). In agreement, altered IL-10 and IL-12 production in 
Cul3Δmye macrophages were all normalized to the levels in 
WT cells by additional Nrf2 deletion (Fig. 5, A and D). These 
findings clearly state that elevated Nrf2 is responsible for in-
creased OGT expression and STAT3 O-GlcNAcylation, as 
well as defective STAT3–IL-10 axis in Cul3Δmye macrophages. 
Normalization of OGT expression and total O-GlcNAc sig-
nal in DKO cells prompted us to test whether DKO cells 
were sensitive to PUG NAc-repressed STAT3–IL-10 axis, as 
observed in WT cells (Fig. 4 C). PUG NAc treatment caused a 
significant decrease in LPS-induced STAT3 phosphorylation 
(Fig. 5 E) and IL-10 production (Fig. 5 F) in Nrf2−/− or DKO 
macrophages, suggesting that Nrf2−/− or DKO macrophages 
show sensitivity to PUG NAc-inhibited STAT3 phosphoryla-
tion and IL-10 production similar to that of WT cells.
We further tested whether pharmacological activation 
of Nrf2 can increases OGT expression. Sulforaphane (SFN), 
tert-Butylhydroquinone (tBHQ), and dimethyl fumarate 
(DMF) are widely used Nrf2 activators (Jaramillo and Zhang, 
2013). As expected, treatment of cells with the chemicals 
caused an increase in Nrf2 transcriptional activity (Fig. 5 G, 
bottom) and Nrf2 protein accumulation (Fig. 5 H). Interest-
ingly, these chemicals also increased OGT at the transcript 
(Fig. 5 G, top) and protein (Fig. 5 H) levels, as well as total 
O-GlcNAc signals, in WT macrophages but not in Nrf2−/− 
macrophages, indicating Nrf2-mediated transcriptional activa-
tion of OGT and OGT-mediated protein O-GlcNAcylation. 
As an ultimate test of Nrf2-mediated OGT expression in 
Cul3Δmye macrophages, we performed ChIP analysis to exam-
ine whether Nrf2 directly enhances Ogt gene transcription 
by binding to the Ogt promoter region. Cul3Δmye macro-
phages showed enhanced Nrf2 binding at the Ogt promoter 
in the absence or presence of LPS stimulation (Fig. 5 F). De-
spite causing enhanced binding of Nrf2 at the Ogt promoter, 
short-term LPS challenge actually down-regulated Ogt in 
macrophages (Fig. 3 C), suggesting that additional inhibitory 
mechanisms exist to repress Ogt transcription. In sum, these 
results indicate that elevated Nrf2 caused by CUL3 deficiency 
promotes OGT expression and STAT3 O-GlcNAcylation, 
which subsequently affects STAT3 phosphorylation and 
IL-10 production (Fig. S2).
cul3Δmye mice are more susceptible to 
experimental colitis and cAc
Numerous studies have established STAT3 and IL-10 as key 
mediators of intestinal inflammation and tumorigenesis (Yu et 
al., 2009; Grivennikov et al., 2010; O’Shea and Plenge, 2012; 
West et al., 2015). For example, myeloid deletion of Stat3 
causes more severe intestinal inflammation during chemically 
induced colitis (Takeda et al., 1999). Il10-deficient mice de-
velop spontaneous colitis (Moran et al., 2009). We studied the 
function of myeloid-derived CUL3 in intestinal inflammation 
during experimental colitis. Mice were challenged with 3% 
dextran sulfate sodium (DSS) for 5 d, and survival was assayed 
for 12 d (Wirtz et al., 2007). Cul3Δmye mice demonstrated 
significantly exacerbated mortality, weight loss, bleeding, di-
arrhea, and colon length shortening compared with WT mice 
(Fig. 6, A–E). Histological analysis revealed increased immune 
cell infiltration in DSS-treated Cul3Δmye mice (Fig. 6 F). To 
further evaluate the colonic inflammatory response induced 
by DSS treatment, colon explant cultures were established 
from untreated or DSS-treated mice. Production of inflam-
matory cytokines such as IL-1β, IL-6, and IL-12p70 were sig-
nificantly enhanced in colon explant culture from Cul3Δmye 
mice, indicating exacerbated colonic inflammation (Fig. 6 G). 
In sharp contrast, IL-10 production in colon explant culture 
from Cul3Δmye mice was significantly decreased. In addition, 
STAT3 phosphorylation in colon macrophages was also sig-
nificantly decreased in Cul3Δmye mice with colitis compared 
with those from WT mice with colitis, which was consistent 
with defective STAT3 phosphorylation in Cul3Δmye macro-
phages in vitro (Fig. 6 H).
We have shown that Nrf2 deletion rescued defective 
STAT3 phosphorylation and IL-10 production in Cul3Δmye 
macrophages (Fig.  5, A–D). To test whether Nrf2 deletion 
could abolish the DSS-colitis phenotype in Cul3Δmye mice, we 
generated BM chimeric mice in which lethally irradiated WT 
mice were reconstituted with BM cells isolated from Cul3fl/fl, 
Cul3Δmye, or Cul3ΔmyeNrf2−/− donor mice. Six weeks later, 
mice were subjected to the DSS-colitis model. We found that 
mice reconstituted with Cul3Δmye BM cells showed increased 
disease severity compared with the mice with WT BM cells, 
including exacerbated weight loss, bleeding, diarrhea, colon 
length shortening, inflammatory cytokine production, and 
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decreased IL-10 production (Fig. 6, I–M). This phenotype was 
consistent with the increased disease severity in Cul3Δmye mice. 
In contrast, mice with Cul3ΔmyeNrf2−/− BM cells showed im-
proved disease outcomes compared with mice with Cul3Δmye 
BM cells, indicating that Nrf2 mediates the in vivo function 
of myeloid-derived Cul3 in the DSS-colitis model.
We next evaluated the function of myeloid-derived 
CUL3 in the development of an inflammation-driven CAC 
model induced with azoxymethane (AOM) plus three cycles 
of 2.5% DSS (Fig. 7 A; Wirtz et al., 2007). Over the entire 
course of the CAC model, AOM + DSS–treated Cul3Δmye 
mice showed a significant decrease in survival and exacer-
bated weight loss, bleeding, and diarrhea (Fig. 7, B–E). At the 
end of the CAC model, histological analyses revealed mac-
roscopic colon polyps in the distal colons and rectums from 
the majority of AOM + DSS–treated mice. The maximal 
cross-sectional diameter (Fig. 7 F) and number (Fig. 7 G) of 
macroscopic polyps were significantly increased in Cul3Δmye 
mice compared with WT mice. Hematoxylin and eosin 
(H&E) staining of colon tissues revealed increased number 
Figure 5. nrf2 promotes oGt expression in cul3Δmye macrophages. (A–D) Cul3ΔmyeNrf2−/− DKO mice were generated. BMMs generated from mice with 
the indicated genotypes were left untreated or stimulated with 200 ng/ml LPS for the indicated periods. Transcript of Ogt, Il10, Il12a, Nrf2, and Nqo1 (A), 
STAT3 phosphorylation and total O-GlcNAc signal (B), STAT3 O-GlcNAcylation (C), and IL-10 and IL-12p70 proteins in the supernatants (D) were measured. 
NT, not treated. (E and F) BMMs of the indicated genotypes were left untreated or stimulated with LPS for 6 or 16 h in the absence or presence of 100 µM 
PUG NAc. STAT3 phosphorylation (Y705) and total protein O-GlcNAcylation (E) and IL-10 protein (F) were assayed by immunoblotting and ELI SA, respectively. 
(G and H) WT and Nrf2−/− BMMs were treated with various Nrf2 activators for 16 h, including SFN (0.4 or 1 µM), tBHQ (2 or 5 µM), and DMF (10 or 40 µM). 
Transcript of Ogt and Nqo1 (G) and OGT, Nrf2, and total O-GlcNAc signal (H) were measured with RT-PCR and immunoblotting, respectively. (I) ChIP assay 
of the binding of Nrf2 at the promoter region of Ogt gene in Cul3fl/fl and Cul3Δmye BMMs left untreated or stimulated with LPS for 3 or 6 h. The results are 
representative of three independent experiments and are expressed as mean ± SD. *, P < 0.05 versus controls.
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Figure 6. cul3Δmye mice show increased susceptibility to chemically induced colitis. (A–H) Cul3fl/fl and Cul3Δmye mice were provided with drinking 
water containing 3% DSS for 5 d, followed by regular water for 5 d. (A–D) Kaplan–Meier plot of animal survival (A), body weight loss (B), bleeding score (C), 
and diarrhea score (D) in Cul3fl/fl (n = 35) and Cul3Δmye (n = 32) mice. (E) Representative colon photos (left) and quantification of colon length (right) of DSS-
treated Cul3fl/fl and Cul3Δmye mice. (F) H&E staining of colons showing histopathology such as crypt loss and immune cell infiltration. Bar, 50 µm. (G) IL-1β, 
IL-6, IL-12p70, and IL-10 in colon explant cultures were measured by ELI SA. (H) Histogram (left) and quantification of STAT3 phosphorylation (right) in colon 
macrophages (CD11b+F4/80+) was assayed by FACS analysis. NT, not treated. (I–M) Lethally irradiated C57BL/6 mice were reconstituted with BM cells from 
Cul3fl/fl, Cul3Δmye, or Cul3ΔmyeNrf2−/− donor mice (n = 10 per group), followed by DSS-colitis induction as described in A–H. (I–L) Body weight loss (I), bleeding 
score (J), diarrhea score (K), and quantification of colon length (L) were calculated. (M) IL-6 and IL-10 in colon explant cultures were measured by ELI SA. The 
results shown are representative of three independent experiments and are expressed as mean ± SD. *, P < 0.05 versus controls.
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and size of dysplastic lesions in AOM + DSS–treated Cul3Δmye 
mice, which was accompanied by enhanced immune cell in-
filtration (Fig. 7 H). In addition, STAT3 phosphorylation in 
colon macrophages was significantly decreased in Cul3Δmye 
mice (Fig.  7  I). In agreement, Cul3Δmye mice showed in-
creased inflammatory cytokine production but decreased 
IL-10 production in colon tissue explant culture compared 
with WT mice (Fig. 7 J). In summary, these in vivo animal 
experiments suggest that myeloid deletion of CUL3 caused 
defective STAT3–IL-10 activation and exacerbated colonic 
inflammation and inflammation-driven tumors.
dIScuSSIon
This study demonstrates an inhibitory effect of OGT-me-
diated STAT3 O-GlcNAcylation on macrophage STAT3 
phosphorylation and IL-10 production (Fig. S4). STAT3 is 
a pleotropic transcription factor that mediates the transcrip-
tion of numerous proteins involved in fundamental biolog-
ical activities, including immune response, metabolism, cell 
cycle control, and development (Stark and Darnell, 2012). 
Upon stimulation with many cytokines, TLR agonists, and 
growth factors, STAT3 is activated by phosphorylation at 
T705 and S727. Recent studies have identified additional 
posttranslational modifications on STAT3 other than phos-
phorylation, including methylation on K140 and acetylation 
on K685 (Stark and Darnell, 2012). One previous study also 
reported O-GlcNAcylated STAT3 in 3T3-L1 adipocytes 
that was increased after insulin stimulation (Whelan et al., 
2008). However, because of the lack of detailed information 
about the STAT3 O-GlcNAcylation site, it was difficult to 
test the causal relationship between STAT3 O-GlcNAcyla-
tion and its function. Our studies detected O-GlcNAcylated 
STAT3 in macrophages. We also identified T717 as the key 
O-GlcNAcylation site on STAT3 by unbiased LC-MS/MS 
analysis, followed by confirmatory studies of testing indi-
vidual T→A or S→A mutants. Importantly, loss of O-Glc-
NAcylation by T717A mutation leads to enhanced STAT3 
phosphorylation and transcriptional activity, which strongly 
argues that O-GlcNAcylation exerts an intrinsic inhibitory 
effect on STAT3 phosphorylation. These findings thus ex-
pand our current understanding of metabolic regulation of 
immune signaling pathways and highlight an essential role of 
immunometabolism in regulating immunity, inflammation, 
and inflammatory diseases.
Because of well-established cross-regulation between 
O-GlcNAcylation and phosphorylation (Hart et al., 2011), 
it is reasonable to predict that OGT-mediated O-GlcNAc-
ylation plays a pivotal role in immune signaling and inflam-
mation. Indeed, the studies of O-GlcNAc signaling in the 
immune system support the concept that O-GlcNAcylation 
enhances the activation of inflammatory immune signaling 
such as NF-κB (Yang et al., 2008). This notion is consistent 
with the observation that high glucose promotes inflamma-
tion (Yang et al., 2008). Several key molecules in TLR and 
NF-κB signaling pathways have been identified to be O- 
GlcNAcylated. For example, O-GlcNAcylation of IKKβ at 
S733 (Kawauchi et al., 2009), NF-κB p65 at T352 (Yang et al., 
2008) and T305 (Allison et al., 2012), and c-Rel at S350 (Ra-
makrishnan et al., 2013) enhances their transcriptional activ-
ities. O-GlcNAcylation of TAB1 at S395, an important TLR 
signaling molecule, increased downstream NF-κB activation 
and cytokine production (Pathak et al., 2012). A recent study 
reported that mouse embryonic fibroblasts derived from a 
heterozygous O-GlcNAcase gene-deletion (Oga+/−) mouse 
strain contained elevated total O-GlcNAc signal, which led 
to increased promoter binding activity of p65 and cytokine 
production (Yang et al., 2015b). As a result, Oga+/− mice ex-
hibited increased susceptibility to the DSS-colitis model. Our 
Cul3Δmye mice showed a phenotype similar to that of Oga+/− 
mice in the DSS-colitis model, indicating that O-GlcNAc 
signaling indeed promotes intestinal inflammation. Mean-
while, we found that elevated OGT protein and total O- 
GlcNAcylation caused defective activation of anti-inflam-
matory signaling pathway STAT3–IL-10 in Cul3Δmye macro-
phages. Therefore, it is reasonable to conclude that O-GlcNAc 
signaling affects inflammatory response through both pro- 
and anti-inflammatory signaling pathways. In addition to its 
classic enzymatic function, OGT also possesses enzymatic 
activity–independent function as a scaffold protein. For ex-
ample, N-terminal truncated OGT, which lacks its enzymatic 
activity domain in C terminus, exhibited an inhibitory effect 
on gene transcription similar to that of full-length OGT in 
an overexpressing reporter system (Yang et al., 2002). This 
was caused by the requirement of N-terminal, but not C-ter-
minal, portion of OGT binding to a critical transcriptional 
repressor, mSin3A (Yang et al., 2002). That study indicates 
that the enzymatic activity is not absolutely required for the 
function of OGT as transcriptional modulator. To fully un-
derstand enzymatic activity–dependent versus –independent 
effects of OGT on NF-κB signaling, a gene-deletion system 
is required that is further reconstituted with full-length ver-
sus N- or C-terminal OGT.
CUL3-formed E3 ubiquitin ligase has been indicated 
to target more than 100 proteins for ubiquitination and deg-
radation including Nrf2, a master transcription factor for the 
antioxidative stress response (Genschik et al., 2013). We in-
deed observed that CUL3 deficiency results in increased Nrf2 
protein accumulation, confirming a nonredundant function 
of CUL3 in maintaining Nrf2 protein at a low basal level. 
Although numerous previous studies have established that 
Nrf2 protects against oxidative stress–induced tissue damage 
through transcriptional activation of genes encoding a wide 
range of phase II detoxifying enzymes and antioxidants (Jara-
millo and Zhang, 2013), some Nrf2-dependent effects could 
not be explained by its antioxidant function. Furthermore, 
the prolonged activation of Nrf2 has been shown to promote 
tissue damage, which again may be independent of its anti-
oxidant function (Jaramillo and Zhang, 2013). For example, 
hyperactivated Nrf2 in Atg7-deficient liver has been shown 
to promote hepatocyte damage, but the underlying mecha-
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Figure 7. cul3Δmye mice are more susceptible to cAc model. (A) Schematic of AOM/DSS model of CAC. (B–E) Kaplan–Meier plot of animal survival (B), 
body weight loss (C), bleeding score (D), and diarrhea score (E) in Cul3fl/fl (n = 26) and Cul3Δmye (n = 22) mice after induction of CAC using AOM/DSS. (F) 
Macroscopic polyps (arrows) were identified in the distal and mid-colons isolated from Cul3fl/fl and Cul3Δmye mice that had completed the entire course of 
CAC model (left). The maximal cross-sectional diameter was quantified (right). (G) The number of macroscopic polyps was quantified. (H) H&E staining of 
colons showing histopathology such as crypt loss, immune cell infiltration, and polyp formation in Cul3fl/fl and Cul3Δmye mice that had completed the entire 
course of CAC model. Bars, 50 µm. (I) Histogram (left) and quantification of STAT3 phosphorylation (right) in colon macrophages (CD11b+F4/80+) assayed by 
FACS analysis (H). MFI, mean fluorescence intensity. (J) IL-1β, IL-6, IL-12p70, and IL-10 in colon explant cultures were measured by ELI SA. The results shown 
are representative of two independent experiments and are expressed as mean ± SD. *, P < 0.05 versus controls.
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nism was not understood (Komatsu et al., 2010). It is highly 
possible that additional unknown Nrf2 target molecules and 
pathways exist to mediate pathological effect when Nrf2 is 
highly activated. Recent studies have shown that Nrf2 plays 
an essential role in mediating glucose and glutamine met-
abolic pathways (Mitsuishi et al., 2012; Singh et al., 2013). 
Using unbiased MS analysis, our study identified OGT 
as a novel transcriptional target of Nrf2, thus highlighting 
Nrf2-targeted metabolic pathways as important mechanisms 
modulating cell signaling. However, we also found that Nrf2 
is not required for baseline OGT expression. Therefore, the 
molecular mechanism of OGT transcriptional control re-
mains largely unknown. Interestingly, recent studies identified 
additional transcriptional factors other than Nrf2 as essential 
binding partners with CUL3, such as PLZF (promyelocytic 
leukemia zinc finger) and BCL6 (B cell lymphoma 6), in reg-
ulating NKT and B cell development (Mathew et al., 2012, 
2014). Therefore, additional CUL3 target proteins other than 
Nrf2 may regulate baseline OGT transcription, which re-
quires further investigation.
In addition to activation of the innate immune response, 
T cell activation and subtype skewing toward T helper 1 (Th1) 
and Th17 have also been indicated in the initiation and devel-
opment of intestinal inflammation and inflammation-driven 
tumor (West et al., 2015). Genome-wide association studies 
of human IBD have identified a tight link between Th1- and 
Th17-related gene polymorphism and intestinal inflamma-
tion (Jostins et al., 2012). We detected significantly increased 
IL-6 and IL-12 production in colon tissues from Cul3Δmye 
mice in the DSS-colitis and CAC animal models, which was 
associated with exacerbated colonic inflammation and tum-
origenesis. Because IL-6 and IL-12 are important inducing 
cytokines for Th17 and Th1 cell differentiation, respectively, 
further studies are warranted to explore the contribution of  T 
cell–mediated inflammatory response to the disease severity 
affected by O-GlcNAc signaling.
In summary, our results provide an association between 
OGT-mediated glucose metabolism pathway and essential 
immune signaling in the innate immune system and expand 
our current understanding of metabolic regulation of the im-
mune function and inflammation-associated diseases. Because 
of the complexity of established OGT target proteins, it is 
highly possible that OGT may affect macrophage function 
other than STAT3 and IL-10 production, requiring further 
investigation. Taking into account the other important roles 
of OGT in the adaptive immune system (Swamy et al., 2016) 
and tumorigenesis (Slawson and Hart, 2011), pharmacologi-
cal modification of OGT activity presents a new therapeutic 
strategy for inflammation and inflammation-driven cancer.
MAtErIALS And MEtHodS
Mice
Cul3Δmye mice were generated by crossing Cul3fl/fl mice 
(McEvoy et al., 2007) with lysosome M-Cre mice. C57BL/6 
mice, lysosome M-Cre mice, and Nrf2−/− mice were pur-
chased from The Jackson Laboratory. Mice were treated in 
accordance with the National Institutes of Health Guide for 
the Care and Use of Laboratory Animals and the Institu-
tional Animal Care and Use Committee of the University of 
Nebraska Medical Center.
reagents and antibodies
Ultrapure LPS and CpG oligonucleotide (ODN1826) were 
from InvivoGen. Recombinant murine IL-4, IL-6, and IFN-γ 
were from PeproTech. Pam3Cys was from EMC Microcollec-
tions. PUG NAc, Tm, GlcNAc, SFN, tBHQ, DMF, and AOM 
were from Sigma-Aldrich. DSS was from TDB Consultancy 
AB. Antibodies for immunoblotting included Phospho-Stat 
Antibody Sampler kit containing anti–p-STAT1 (Y701), an-
ti–p-STAT3 (Y705), anti–p-STAT6 (Y641), anti–p-IKKα/β 
(S176/180), anti-IKKβ, anti–p-IκBα (S32), anti-IκBα, anti– 
p-p65 (S536), anti-p65, anti–p-ERK1/2 (T202/Y204), 
anti–p-JNK (T183/Y185), anti–p-p38 (T180/Y182), anti- 
OGT and anti–O-GlcNAc (Cell Signaling Technology), 
anti-STAT3, anti-SOCS3, anti-CHOP, HRP-conjugated 
anti–β-actin (Santa Cruz Biotechnology, Inc.), HRP-conju-
gated anti-FLAG (Sigma-Aldrich), anti-Xbp1s (BioLegend), 
and anti-CUL3 (BD). Anti-Nrf2 (Abcam) antibody was used 
for both immunoblotting and immunoprecipitation.
cell culture and stimulation
BMMs were generated from Cul3fl/fl and Cul3Δmye mice in 
the presence of L-929 conditioned medium. Peritoneal mac-
rophages were isolated by peritoneal lavage with 10 ml sterile 
DPBS containing 2% FBS. Macrophages were stimulated with 
LPS (200 ng/ml) for various time points as indicated in the 
figure legends. Cell culture supernatants were collected for 
ELI SA. Cells were collected for RT-PCR or immunoblotting.
rt-Pcr
Total RNA was extracted from in vitro cultured BMMs using 
Trisure (Bioline). cDNA synthesis was performed with Mo-
loney murine leukemia virus reverse transcription (Invitro-
gen) at 38°C for 60 min. Real-time PCR was performed 
using SYBR Green PCR Master Mix in an Applied Bio-
systems StepOnePlus detection system. The fold difference 
in mRNA expression between treatment groups was deter-
mined by a standard ΔΔCt method. β-actin was analyzed as 
an internal control. The primer sequences of individual genes 
are listed in Table S1.
Immunoblotting
Electrophoresis of proteins was performed by using the NuP-
AGE system (Invitrogen) according to the manufacturer’s pro-
tocol. In brief, cultured BMMs were collected and lysed with 
RIPA buffer. Proteins were separated on a NuPAGE gel and 
transferred onto nitrocellulose membranes (Bio-Rad Labora-
tories). Appropriate primary antibodies and HRP-conjugated 
secondary antibodies were used, and proteins were detected 
using enhanced chemiluminescent (ECL) reagent (Thermo 
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Fisher Scientific). Images were acquired with ChemiDoc MP 
System (Bio-Rad Laboratories).
ELI SA
Cytokines generated by in vitro cultured BMMs and colon 
explants were quantified using the ELI SA Set for mouse 
IL-1β, IL-6, IL-10, and IL-12p70 (BD) according to the 
manufacturer’s protocol.
Site-directed mutagenesis
pcDNA3 vector containing FLAG-tagged WT or S727A 
mouse Stat3 was a gift from A. Baldwin (University of North 
Carolina at Chapel Hill). Phusion Site-Directed mutagenesis 
kit (Thermo Fisher Scientific) was used to generate a series 
of STAT3 mutant constructs according to the manufacturer’s 
instructions. Primers used during mutagenesis PCR can be 
found in Table S2. The complete nucleotide sequences of all 
STAT3 mutants were double-checked by sequencing.
cell transfection
BMMs were transfected with WT or mutant forms of STAT3 
with X-tremeGENE HP DNA Transfection Reagent accord-
ing to the manufacturer’s directions (Roche). The transfection 
efficiency was predetermined by FACS analysis of GFP by 
transfecting macrophages with pmaxGFP. For siRNA-based 
Ogt gene knockdown, BMMs were transfected with siScr or 
siOgt (Integrated DNA Technologies) using Lipofectamine 
RNAiMAX Transfection Reagent according to the manufac-
turer’s directions (Thermo Fisher Scientific).
chIP assay
The ChIP procedure was performed using an assay kit (EMD 
Millipore) according to the manufacturer’s instructions. In 
brief, 3 × 106 BMMs were left untreated or stimulated with 
200 ng/ml LPS for 3 or 6 h. DNA–protein structure was then 
cross-linked by 1% formaldehyde for 10 min at 37°C. Cells 
were collected and lysed in 400 µl SDS lysis buffer. The re-
sulting lysate was sonicated to obtain DNA fragments ranging 
from 200 to 1,000 bp using a Branson Sonifier SLPe under 
the following condition: six times for periods of 15  s each. 
After centrifugation, the supernatant containing chromatin 
was diluted, and an aliquot (2% volume) was saved to indicate 
the input DNA in each sample. The remaining chromatin 
fractions were precleared with salmon sperm DNA/protein 
A agarose beads followed by immunoprecipitation with anti- 
STAT3 or anti-Nrf2 antibody overnight at 4°C with gen-
tle rotation. Cross-linking was reversed for 4 h at 65°C and 
was followed by proteinase K digestion. DNA was purified 
by standard phenol/chloroform and ethanol precipitation 
and subjected to real-time PCR. Primers are as follows: for 
mouse Il10 promoter, forward 5′-CGA CCA GTT CTT TAG 
CGC TTA-3′ and reverse 5′-TGT TCT TGG TCC CCC TTT 
TA-3′, which amplifies 172 bp from −180 to −9 relative to 
the transcription start site; for mouse Ogt promoter, forward 
5′-GTA CTT TAG CGC TTG CCA AA-3′ and reverse 5′-
CAT GAC TGT AGA GAG CGC ATG-3′, which amplifies 173 
bp from −293 to −121 relative to the transcription start site.
Microarray
Total RNA was extracted from Cul3fl/fl and Cul3Δmye BMMs 
left untreated or stimulated with 200 ng/ml LPS for 4 h using 
RNeasy Mini kit (QIA GEN) according to the manufactur-
er’s instructions. The quality of total RNA was tested using 
Bioanalyzer 2000 (Agilent Technologies). RNA was digested 
with the RNase-Free DNase set and amplified into antisense 
RNA (aRNA). After one-color (Cy3) labeling, aRNA was 
loaded into a SurePrint G3 Mouse Gene Expression 8X60K 
Microarray (Agilent) and hybridized overnight in a hybrid-
ization oven. The hybridized array was washed and scanned, 
and data were extracted from the scanned image using Fea-
ture Extraction version 10.7 (Agilent Technologies).
tm in vivo treatment
C57BL/6 mice were injected intraperitoneally with 1 mg/kg 
body weight Tm in sterile dextrose (150 mM) or vehicle con-
trol, as previously described (Ozcan et al., 2004). Liver tissues 
were collected 6  h after injection for biochemical analysis 
of STAT3 phosphorylation and O-GlcNAcylation and MS 
analysis of STAT3 O-GlcNAcylation sites.
StAt3 o-GlcnAcylation site mapping
Immunoprecipitated STAT3 from total liver lysates or BMMs 
was subjected to SDS-PAGE. The bands corresponding to 
STAT3 were excised, and the proteins were reduced, al-
kylated, and in-gel digested with trypsin. The peptides were 
extracted, lyophilized, resuspended in 2%ACN/0.1% for-
mic acid, and analyzed by LC-MS/MS using a nanoAcquity 
(Waters Corp.) coupled to an LTQ Orbitrap Velos (Thermo 
Fisher Scientific). Samples were injected onto an in-house 
packed C18AQ (Michrom Biosciences) trap column (100 
µm internal diameter × 2 cm, 5 µm particle size) and were 
washed with 1% ACN/0.1% formic acid for 20 min at 2 µl/
min, then loaded onto an analytical column (C18AQ, 100 
µm internal diameter × 22 cm, 5 µm particle size). The lin-
ear gradient for separation consisted of 5–36% mobile phase 
B over 120 min at a 250-nl/min flow rate, where mobile 
phase A was 0.1% formic acid in water and mobile phase B 
was 0.1% formic acid in ACN. The LTQ Orbitrap Velos was 
operated in data-dependent mode: the 10 most intense pre-
cursors were selected for subsequent collision-induced dis-
sociation (CID) fragmentation. Resolution for the precursor 
scan (m/z 300–2,000) was set to 60,000 at m/z 400 with a 
target value of 106 ions. The MS/MS scans were acquired in 
the linear ion trap with a target value of 1,000. The normal-
ized collision energy was set to 35% for CID. Precursors with 
unknown charge or a charge state of 1 and 4 or higher were 
excluded. Raw data files were processed using Proteome Dis-
coverer version 2.0 (Thermo Fisher Scientific). Peak lists were 
searched against a Homo sapiens Uniprot database using Se-
quest. The following parameters were used to identify tryptic 
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peptides for protein identification: 10 ppm precursor ion mass 
tolerance; 0.6 D product ion mass tolerance; up to two missed 
trypsin cleavage sites; carbamidomethylation of Cys set as a 
fixed modification; and hexNAc (+203.0794 D) of N/S/T, 
oxidation of M, and phosphorylation of S/T/Y set as variable 
modifications. The Percolator node was used to determine 
false discovery rates (FDRs), and a peptide FDR of 5% were 
used to filter all results.
Metabolomics
3 × 106 BMMs were left untreated or were stimulated with 
200 ng/ml LPS for 4  h. Media from biological duplicates 
were fully aspirated, and 4 ml of 80% (vol/vol) methanol was 
added at dry ice temperatures. Cells were collected into con-
ical tubes, and debris was removed through centrifugation 
at 2,000 g for 15 min. The resulting supernatant was evap-
orated using a refrigerated SpeedVac. Samples were resus-
pended using 20 µl HPLC-grade water for targeted LC-MS/
MS. 10 µl was injected and analyzed using a 5500 QTR AP 
hybrid triple-quadrupole mass spectrometer (Sciex) coupled 
to a Prominence UFLC HPLC system (Shimadzu) via se-
lected reaction monitoring (SRM) of a total of 261 endog-
enous water-soluble metabolites for steady-state analyses of 
samples. Some metabolites were targeted in both positive 
and negative ion mode for a total of 296 SRM transitions 
using positive/negative switching. ESI voltage was +4,900 
V in positive ion mode and −4,500 V in negative ion mode. 
The dwell time was 4 ms per SRM transition, and the total 
cycle time was 1.89 s. Approximately 9–12 data points were 
acquired per detected metabolite. Samples were delivered to 
the MS via normal-phase chromatography using a 4.6-mm 
internal diameter × 10-cm Amide XBridge HIL IC column 
(Waters Corp.) at 400 µl/min. Gradients were run starting 
from 85% buffer B (HPLC grade acetonitrile) to 42% B from 
0 to 5 min; 42% B to 0% B from 5 to 16 min; 0% B held from 
16 to 24 min; 0% B to 85% B from 24 to 25 min; and 85% 
B held for 7 min to re-equilibrate the column. Buffer A was 
comprised of 20 mM ammonium hydroxide/20 mM ammo-
nium acetate, pH 9.0, in water/acetonitrile (95:5). Peak areas 
from the total ion current for each metabolite SRM transi-
tion were integrated using MultiQuant v2.1 software (Sciex). 
Data analysis was performed in Cluster3.0 and TreeViewer.
colitis and cAc animal model
The induction of acute colitis by DSS (Wirtz et al., 2007) 
and CAC by AOM + DSS (Neufert et al., 2007) has been de-
scribed previously. For the DSS-induced colitis model, Cul3fl/fl 
and Cul3Δmye mice were subjected to one cycle of 3% DSS 
exposure for 5 d. Mice were sacrificed, and inflammation as-
sessments were made at day 7 after removal of DSS challenge. 
To evaluate tumorigenesis, mice received a single intraperi-
toneal injection (10 mg/kg body weight) of AOM followed 
by three cycles of DSS exposure. Mice were sacrificed, and 
tumor assessments were made 8 wk after AOM injection or 
when moribund. Colon lengths and histopathology were 
measured for each animal at the completion of each study. 
The bleeding score and diarrhea score were calculated as pre-
viously described (Allen et al., 2010; Salcedo et al., 2010).
BM chimera
Six-week old C57BL/6 mice were lethally irradiated (9.5 Gy). 
BM cells were prepared from femurs and tibiae of Cul3fl/fl, 
Cul3Δmye, or Cul3ΔmyeNrf2−/− donor mice. Irradiated recip-
ient mice were reconstituted with 5 × 106 BM cells via the 
tail vein. After 6 wk, mice were subjected to one cycle of 
3% DSS exposure for 5 d.
Statistics
Statistical analysis was performed with Prism 5.0 for Macin-
tosh. All data are shown as mean ± SD. The mean values for 
biochemical data from each group were compared by Stu-
dent’s t test. Comparisons between multiple time points were 
analyzed by repeated-measures ANO VA with Bonferroni 
post tests. Survival curves were generated by the product limit 
method of Kaplan and Meier, and significance was analyzed 
by log-rank test. In all tests, P values of less than 0.05 were 
considered statistically significant.
online supplemental material
Fig. S1 shows the generation of myeloid conditional Cul3 
gene deletion mice (Cul3Δmye). Fig. S2 shows the MS analysis 
of STAT3 O-GlcNAcylation in mouse BMMs. Fig. S3 shows 
no involvement of protein PP1 in the defective STAT3 phos-
phorylation in Cul3Δmye BMMs. Fig. S4 shows a schematic 
of CUL3-Nrf2 signaling-modulated OGT expression and 
STAT3 O-GlcNAcylation on STAT3 phosphorylation and 
IL-10 production in macrophages. Table S1 shows the list of 
RT-PCR primer sets for various mouse genes. Table S2 shows 
the list of primer sets used in the site-directed mutagenesis 
of STAT3. Table S3 shows the list of genes with increased 
and decreased expression levels in LPS-treated Cul3Δmye mac-
rophages compared with similarly treated WT macrophages. 
Table S4 shows the list of metabolites in LPS-treated Cul3Δmye 
macrophages versus similarly treated WT macrophages.
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